Predicting stomach retention risk before sedated endoscopy
Part of Cancer, Digestive system clinical trials.
This study is building a tool to predict if a patient's stomach will empty normally before a sedated upper endoscopy (gastroscopy). It tests risk factors that help doctors plan safer procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a sedated upper endoscopy or both upper and lower endoscopy.
- You do not have active bleeding in the upper digestive tract (like vomiting blood or black stools) in the past 24 hours.
- You are not having an emergency endoscopy.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stomach mapping device (BSGM) to see how a prokinetic medication changes stomach activity in people with gastroparesis or functional dyspepsia. If you qualify, you'll have two non-invasive recordings—one before and one during your treatment.
This study is looking at people at high risk for stomach cancer to see if doctors can predict from their endoscopy results whether they might develop cancer or pre-cancerous changes. It focuses on those with H. pylori infection or atrophic gastritis (thinning of the stomach lining) but no current cancer, so they can be monitored more closely.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study compares using an ultrasound before a gastroscopy (a tube with a camera to look inside your stomach) with the usual method of suctioning stomach contents. It aims to see if ultrasound can predict what is in the stomach, which may help make the procedure safer and more comfortable.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
Hear when a new Gastric Cancer Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.